Agilent Technologies Completes Acquisition of ProZyme

SANTA CLARA, Calif.–(BUSINESS WIRE)–Aug. 1, 2018– Agilent Technologies, Inc. (NYSE:A) today announced that it has completed the acquisition of ProZyme, Inc., a leading provider of glycan reagents, kits and standards. This acquisition expands Agilent’s portfolio of biopharma consumables. Founded in 1990, Hayward-Calif. based ProZyme is an industry leading developer and manufacturer of glycan reagents, kits... Read more

Agilent Technologies Completes Acquisition of ProZyme

SANTA CLARA, Calif.–(BUSINESS WIRE)–Aug. 1, 2018– Agilent Technologies, Inc. (NYSE:A) today announced that it has completed the acquisition of ProZyme, Inc., a leading provider of glycan reagents, kits and standards. This acquisition expands Agilent’s portfolio of biopharma consumables. Founded in 1990, Hayward-Calif. based ProZyme is an industry leading developer and manufacturer of glycan reagents, kits... Read more

Agilent Technologies Completes Acquisition of ProZyme

SANTA CLARA, Calif.–(BUSINESS WIRE)–Aug. 1, 2018– Agilent Technologies, Inc. (NYSE:A) today announced that it has completed the acquisition of ProZyme, Inc., a leading provider of glycan reagents, kits and standards. This acquisition expands Agilent’s portfolio of biopharma consumables. Founded in 1990, Hayward-Calif. based ProZyme is an industry leading developer and manufacturer of glycan reagents, kits... Read more

Agilent Technologies Completes Acquisition of ProZyme

Agilent Technologies Completes Acquisition of ProZyme SANTA CLARA, Calif., Aug 1, 2018 Agilent Technologies Inc. (NYSE: A) today announced that it has completed the acquisition of ProZyme, Inc., a leading provider of glycan reagents, kits and standards. This acquisition expands Agilent’s portfolio of biopharma consumables. Founded in 1990, Hayward-Calif. based ProZyme is an industry leading... Read more

Announcing the handover of EDS systems sales & maintenance and the completion of the OEM contract with HORIBA, Ltd.

1st August 2018 Oxford Instruments NanoAnalysis, the global leader in microanalysis systems, today announces the termination of its long standing partnership with HORIBA, Ltd for the distribution of EDS systems sales and maintenance work under the EMAX brand in Japan and Asia, and the handover of all activity from Horiba to Oxford Instruments directly. Oxford... Read more

Announcing Transfer of EMAX Series Sales and Maintenance Service Operations

August 1, 2018 July 31, 2018 To Our Valued Customers HORIBA, Ltd. Oxford Instruments Nano Analysis Announcing Transfer of EMAX Series Sales and Maintenance Service Operations Greetings, and we trust that this communication finds your company enjoying strong and prosperous business conditions. Upon this occasion, we wish to convey our most profound gratitude for your... Read more

QIAGEN creates collaboration with Japan’s largest clinical laboratory testing company, SRL, to accelerate launch of companion diagnostics

Hilden, Germany, and Tokyo, Japan, August 1, 2018 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a collaboration with SRL, Inc., the largest clinical testing laboratory company in Japan, to prepare for introduction of new companion diagnostics simultaneous with new drug approvals. The non-exclusive master collaboration agreement for clinical laboratory research services... Read more

AMETEK Acquires Motec GmbH

BERWYN, Pa., July 31, 2018 /PRNewswire/ — AMETEK, Inc. (NYSE: AME) today announced that it has completed the acquisition of Motec GmbH, a leading provider of integrated vision systems serving the high growth mobile machine vision market. Motec’s ruggedized vision products and integrated software solutions provide customers with improved operational efficiency and enhanced safety across... Read more

Roche Purchases Shares in Tender Offer for FMI

Basel, 31 July 2018 Roche Purchases Shares in Tender Offer for FMI Roche (SIX: RO, ROG; OTCQX: RHHBY) and Foundation Medicine, Inc. (NASDAQ:FMI) today announced that Roche’s wholly owned subsidiary 062018 Merger Subsidiary, Inc. has accepted for payment all shares validly tendered and not validly withdrawn pursuant to its tender offer for all outstanding shares... Read more

10x Genomics Partners with BioLegend and Immudex to Extend Research Applications of Its New Single Cell Feature Barcoding Technology

PLEASANTON, CA.—July 31, 2018—10x Genomics, Inc., a company focused on accelerating genomic discovery, today announced that BioLegend and Immudex will be the first 10x Compatible Partners providing products for its new single cell Feature Barcoding Technology, which was revealed at the 2018 Advances in Genome Biology and Technology meeting in February this year. The resulting product innovations, available at the end of... Read more